Continuous glucose monitoring system (CGMS) is a device that provides with the real-time glucose monitoring in diabetes patients. This technology helps diabetes patients to track their glucose levels round-the-clock. CGMS devices monitor glucose levels at an interval of every 5 minutes. CGMS devices are used along with blood glucose meters to provide supplementary information to facilitate better glucose monitoring and treatment. This technology can be used in diabetes type 1 as well as diabetes type 2 patients. Continuous glucose monitoring assist in stabilizing elevated A1C levels, thereby, reducing the risk of developing long-term diabetic complications. The adoption of CGMS technology is expected to increase, owing to its application in artificial/bionic pancreas.

Browse Full Report Visit – http://www.acutemarketreports.com/report/europe-continuous-glucose-monitoring-systems-market

The Europe CGMS market is estimated to garner $351.7 million by 2021, registering a CAGR of 38.0% during the forecast period. This market is expected to witness significant growth from 2015 to 2021, owing to numerous advantages of CGMS such as minimal invasiveness and real-time blood glucose monitoring. In addition, increasing incidence of diabetes cases in Europe, increasing per capita healthcare expenditure, and growing purchasing power on account of high disposable income of individuals have fueled the market growth. Furthermore, ability of CGMS to provide detailed analysis of blood glucose levels and higher precision as compared to traditional blood glucose monitoring has supplemented the market growth. However, high costs associated with CGMS, lack of adequate reimbursement policies, and limited awareness about CGMS among patients are the major factors hampering the growth of the market.

The report segments the Europe CGMS market on the basis of country and components. Based on country, the market is segmented into the U.K., France, Germany, Norway, Sweden, Denmark, Finland and Other Europe. Presently, the Germany leads the Europe CGMS market, owing to its large diabetes patient pool and high healthcare expenditure. The components of the CGMS comprise sensors, transmitters & receivers, and integrated insulin pumps. The sensors segment dominates the market, as the sensor loses its sensitivity after using if for about 5 to 7 days, which requires frequent requirement.

Europe CGMS market has presence of numerous manufacturers that are adopting partnership and collaboration as their strategy to commercialize CGMS. For instance, Senseonics and Rubin Medical have adopted the collaboration strategy to commercialize their CGMS products in Denmark and Sweden. The companies profiled in the report include Medtronic Inc., Dexcom, Inc., Abbott Diabetic care, Senseonics Incorporated, Insulet Corporation, Echo therapeutics, Glysens Inc. and Animas Corporation,

Browse All Reports of This Category – http://www.acutemarketreports.com/category/medical-equipments-market

KEY BENEFITS FOR STAKEHOLDERS:

This report provides an in-depth analysis of the current and emerging market trends and dynamics in the Europe CGMS market.
The European CGMS market is analyzed based on countries such as the U.K., France, Germany, Norway, Sweden, Denmark, Finland, and Other Europe.
An in-depth analysis of key strategies adopted by key manufacturers helps in understanding competitive scenario.
This report provides an exhaustive analysis of the factors that drive and restrict the growth of the Europe CGMS market.
The reimbursement scenario of CGMS devices has been provided in this report.
EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET KEY SEGMENTS:

BY COUNTRY

U.K.
France
Germany
Norway
Sweden
Denmark
Finland
Other
Europe
BY COMPONENTS

Sensors
Transmitters & receivers
Integrated insulin pumps
Chapter: 1 INTRODUCTION
1.1 Market definition and scope
1.2 Research methodology
1.2.1 Secondary research
1.2.2 Primary Research
1.2.3 Analyst Tools and Models

Chapter: 2 EXECUTIVE SUMMARY

Chapter: 3 EUROPE CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)
3.1 Overview
3.1.1 Market size and forecast
3.1.2 Sensor
3.1.3 Transmitter & receivers
3.1.4 Integrated insulin pumps

Chapter: 4 U.K. CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)
4.1 Key market trends
4.2 Key growth factors and opportunities
4.3 Market size and forecast
4.3.1 Sensor
4.3.2 Transmitter & receivers
4.3.3 Integrated insulin pumps
4.4 Reimbursement scenario

Chapter: 5 GERMANY CONTINUOUS GLUCOSE MONITORING SYSTEMS MARKET, 2014-2021 ($THOUSANDS)
5.1 Key market trends
5.2 Key growth factors and opportunities
5.3 Market size and forecast
5.3.1 Sensor
5.3.2 Transmitter & receivers
5.3.3 Integrated insulin pumps
5.4 Reimbursement scenario

Our Blogs :-

http://www.qyresearchreports.net/
http://www.deepresearchreport.com/
http://www.profresearchreport.com/

For Technology News : http://www.mobilecomputingtoday.co.uk/
About – Acute Market Reports :

Acute Market Reports is the most sufficient collection of market intelligence services online. It is your only source that can fulfill all your market research requirements.We provide online reports from over 100 best publishers and upgrade our collection regularly to offer you direct online access to the world’s most comprehensive and recent database with expert perceptions on worldwide industries, products, establishments and trends.

Our team consists of highly motivated market research professionals and they are accountable for creating the groundbreaking technology that we utilize in our search engine operations to easily recognize the most current market research reports online.
Contact Us :
Chris Paul
ACUTE MARKET REPORTS
Office No 101, 1st Floor ,
Aditi Mall, Baner,
Pune, MH, 411045
India
Toll Free(US/CANADA): +1-855-455-8662
India: +91 7755981103
Email : sales@acutemarketreports.com
Website : http://www.acutemarketreports.com